Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
63.64
-2.58 (-3.90%)
Jun 25, 2026, 4:00 PM EDT - Market closed
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $660.55 million as of June 25, 2026. Its market cap has increased by 166.79% in one year.
Market Cap
660.55M
Enterprise Value
442.99M
1-Year Change
166.79%
Ranking
Category
Stock Price
$63.64
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $660.55M, an increase of 1,480.91%. That is a compound annual growth rate of 67.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 660.55M | 5.32% |
| Dec 31, 2025 | 627.18M | 150.23% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oculis Holding AG | 698.09M |
| Relmada Therapeutics | 682.84M |
| Candel Therapeutics | 679.22M |
| Rigel Pharmaceuticals | 676.25M |
| Aclaris Therapeutics | 668.99M |
| Tenax Therapeutics | 660.62M |
| CorMedix | 658.21M |
| SpyGlass Pharma | 653.62M |